Table 1.
Patient test results
| Laboratory measurement | Initial presentation (day 1) | DIC onset (day 28) | 1 week after DIC treatment with nafamostat (day 35) | 2 weeks after initiation of DOAC (day 50) |
|---|---|---|---|---|
| WBC | 6,700 | 6,000 | 12,440 | 8,680 |
| Hb, g/dL | 11.2 | 9.1 | 8.4 | 7.2 |
| Pit × 104 | 11.8 | 3.7 | 30.2 | 29.1 |
| PT-INR | 0.97 | 1.12 | 0.98 | 1.10 |
| APTT, s | 29.1 | 31.4 | 27.9 | 36.0 |
| Fibrinogen | N/A | 62.9 | 374 | 540 |
| D-dimer, μg/mL | N/A | 52.7 | 18.0 | 5.9 |
| AT III, % | N/A | 65 | N/A | N/A |
| TAT, ng/mL | N/A | 121.9 | N/A | N/A |
| Cr, mg/dL | 0.80 | 1.11 | 1.10 | 0.69 |
| BUN, mg/dL | 18.1 | 39.1 | 29 | 20.1 |
| UA, mg/dL | 5.4 | 7.4 | 5.8 | 5.2 |
| Ca, mg/dL (corrected for albumin) | 10.1 | 13.1 | 9.2 | 8.2 |
DIC, disseminated intravascular coagulation; Ca, calcium.